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Abstract 
Several independent analyses, by both epidemiologists and actuaries, have concluded that 
the previous rate of improvement of life expectancy in England and Wales has now slowed 
markedly, and at older ages may even be reversing. However, although these findings have 
led the pension industry to reduce estimates of future liabilities, they have failed to elicit any 
significant concern in the Department of Health. In this essay, we review the evidence on 
changing life expectancy, noting that the problems are greatest among older women. We 
then estimate the gap between what life expectancy is now and what it might have been had 
previous trends continued. At age 85 this is 0.34 years for women and 0.23 for men. We 
argue that recent changes cannot be dismissed as a temporary aberration. While the causes 
of this phenomenon are contested, there is growing evidence to point to the austerity 
policies implemented in recent years as at least a partial explanation. We conclude by 
calling for a fully independent enquiry to ascertain what is happening to life expectancy in 
England and Wales and what should be done about it.   
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Introduction 
In July 2017, the UK’s Institute of Health Equity, using data from the Office for National 
Statistics (ONS), released a briefing on faltering improvements in life expectancy at birth in 
England. It showed that the previous increases of 1 year every 5 years for women, and 1 
year every 3.5 years for men, had slowed since 2010 to 1 year in every 10 for women, and 1 
in every 6 for men.[1] The head of the institute, Professor Sir Michael Marmot, said he was 
‘deeply concerned’ and called for work to discover what had happened as a ‘matter of 
urgency’.[2] In particular, he noted that this could not be dismissed as the population 
reaching the biological limits of longevity, as life expectancy in the United Kingdom (UK) 
continues to lag behind that achieved in many other affluent countries.  
The response by the UK Department of Health (DoH) failed to address his specific points, 
instead stating that ‘Life expectancy continues to increase, with cancer survival rates at a 
record high whilst smoking rates are at an all-time low’.[2] Their first point was not disputed; 
Marmot’s concern was that the rate of improvement had slowed markedly rather than 
stopped. The second point was at best only partly relevant, and the third completely failed to 
address the concerns raised.  
This is not the first time such concerns have been reported, or that the DoH has dismissed 
them so abruptly. In early 2017, our research in the Journal of the Royal Society of Medicine 
(JRSM) raised the alarm about an increase in deaths in England and Wales, particularly in 
the older population, an analysis complicated by delays in publication of the necessary data. 
Although some of the increase could be explained by changes in the age structure of the 
population, there remained a substantial increase, concentrated among older people, that 
could not be. After reviewing other possible causes, like Marmot, we concluded that it was 
not possible to offer a complete explanation and that an urgent, thorough investigation was 
needed.[3, 4] We too received a dismissive response from a DoH spokesperson who stated: 
‘this report is a triumph of personal bias over research’.  
These concerns have not been assuaged by the most recent data on life expectancy for 
England and Wales, released by ONS in September 2017. Figure 1 is based on data from 
the ONS decennial supplement,[5] compiled at 10 year intervals coinciding with censuses, 
which maximises the precision with which rates are calculated. It has been brought up to 
date using the very latest estimates of life expectancy published by ONS in September 
2017.[6] ONS life expectancy estimates are now based on age specific mortality by 
individual year of age up to age 100, and so these estimates are not affected by any issues 
of ‘ageing within bands’.[7]  
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The most recent period has seen one of the greatest slowdown in the rate of improvement 
for both sexes since the 1890s (although there was also a marked slowdown for men in the 
1960s) (Figure 1).  
 
Figure 1: Life expectancy at birth in England and Wales, 1840-2016. Source: ONS 
 
 
Specifically, the most recent rate of improvement in life expectancy for either women or men 
in the most recent years (2010/2 to 2014/16) was between 2.1 and 3.5 times lower than at 
any time between 1981 and 2011. The previous decade that was most similar to the current 
one is 1881-1891. So far, we only have life expectancy data up until 2016. We will not be 
able to compare the whole of the current decade until five years from now. However, 
the current picture should be seen as sufficiently alarming to warrant serious investigation 
before then (before 2022). The most recent data on total number of deaths rising in 2017 
(see below) and the response of the pensions industry adds weight to this claim. 
Although what is now the Department of Health and Social Care appears unperturbed by 
these recent trends, the pension industry has certainly taken note.[8] Price Waterhouse 
Cooper estimates that ‘[a] sharp slowdown in the improvement to life expectancy could wipe 
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£310bn from the pension deficits of thousands of UK companies with final salary schemes’, 
equivalent to a 15% reduction.[9] There is some dispute over the final figure, but there 
appears to be no dispute in the pension industry that future life expectancies are likely to be 
lower than expected.[10] This is especially important, given that those covered by this 
industry tend to be healthier than average.[11] If we no longer expect people in the UK to 
live as long as we thought they would a few years ago, we need to know why. 
We now consider the trends in life expectancy in the older population, compared to what 
could have been expected if previous trends continued, presenting evidence to refute claims 
by some that the trends seen are merely a ‘blip’. We argue that this demands an urgent 
independent investigation, with adequate resources and the power to obtain the necessary 
data for the detailed analyses we believe are required, and to summon ministers and 
officials to give evidence.  
 
Life expectancy for elderly people 
Before 2012, life expectancy for elderly people was rising at an almost constant rate each 
year with some acceleration in the period immediately prior to 2011. This can be seen 
clearly in Table 1, showing the change between consecutive three-year averages (to smooth 
annual fluctuations). A very similar trend is seen for men and women, and for life expectancy 
as measured from either age 65, age 75 or age 85. In every case, what had been consistent 
improvements declined markedly after ‘2008-2010’ and ‘2009-2011’. Given the consistency 
of the earlier trends , this reflected a marked increase in death rates in 2012. Worryingly, in 
the most recent period, there were actual declines in the oldest groups. The worsening of life 
expectancy for women over 85 years was first raised as an issue of immediate concern over 
three years ago,[12] yet it received little attention then, and little since, despite becoming 
much worse year on year. 
Table 1 shows that there is no sign at all of the deceleration slowing down. What started in 
2012 worsened dramatically in 2015, when deaths rose by 5.6%--the largest annual 
percentage increase since the 1960s.[13] While there has been a slight recovery in the most 
recent data, the improvements are still less than half the size of those observed up until 
2010/11. To explore this further, we now compare observed life expectancy with predicted 
trends, or ‘expected’ life expectancy, calculated using regression techniques. 
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Table 1 Change in Life expectancy In England and Wales between overlapping time 
periods by age/sex (years) 
  
Age 65 Age 75 Age 85 
From To Male Female Male Female Male Female 
2004-06 2005-07 0.23 0.16 0.16 0.12 0.05 0.06 
2005-07 2006-08 0.20 0.14 0.14 0.11 0.05 0.04 
2006-08 2007-09 0.22 0.20 0.16 0.15 0.06 0.07 
2007-09 2008-10 0.22 0.19 0.18 0.16 0.07 0.08 
2008-10 2009-11 0.28 0.28 0.22 0.23 0.12 0.15 
2009-11 2010-12 0.15 0.08 0.11 0.05 0.01 -0.01 
2010-12 2011-13 0.12 0.06 0.06 0.04 0.01 -0.01 
2011-13 2012-14 0.11 0.07 0.07 0.05 0.02 0.01 
2012-14 2013-15 0.04 0.00 0.01 -0.02 -0.01 -0.04 
2013-15 2014-16 0.08 0.06 0.07 0.06 0.05 0.04 
Source: ONS, National Life Tables, England & Wales, 2004-06 to 2014-16 
 
Trends in life expectancy for the over 65s 
The over 65s have borne the brunt of the deceleration in life expectancy gains. We have 
shown this in the crude differences in life expectancies, and now examine the gap between 
expected life expectancy, if trends up to 2009-11 had continued, and observed life 
expectancy, using data reported by the ONS, for people of ages 65, 75, and 85 years.[14] 
Note the axes in Figures 2, 3 and 4 do not start at zero. 
The gap between the expected and the observed values varies from 0.49 years in females 
at age 65 years to 0.20 years in males at age 85 years.  
However, it is not the slowing that is the most concerning. Although that should be 
considered an amber warning light, demanding investigation at least, any reversal in life 
expectancy should be considered a red danger sign. This can now be seen clearly for 3 
groups following the change between 2012-14 and 2013-15. For female life expectancy at 
75 years, there was a fall from 13.11 to 13.09 years, for females at age 85 years a fall from 
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6.85 to 6.80 years, and for male life expectancy at 85 years a fall from 5.85 to 5.84 years. 
Life expectancy was not ‘continuing to increase’ for everyone, at the time the DoH’s made its 
assertions. 
 
Figure 2: Life expectancy age 65, England and Wales 
 
 
A temporary change? 
Politicians’ attempts to reassure the public that these changes are only temporary may be 
overly optimistic. Table 2 presents the same data but only reports changes between non-
overlapping three-year periods. The changes in the first two periods are very similar. In 
every case there were rapid improvements in life expectancy for elderly people, which either 
stayed the same or improved slightly until 2012. Then, in the most recent three-year period, 
the improvement for men from age 65 has more than halved (0.65 to 0.27). For women aged 
65 it has reduced to just a quarter of what it had been (0.55 to 0.13).  The most recent 
changes are worst for the very elderly (who are presumably the most frail, or otherwise 
disadvantaged, and potentially most susceptible to what is causing this recent trend). For 
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men aged from 85, the most recent improvement (0.02 years in three years) is a tenth of the 
previous rate of improvement. For women aged from 85, what had been a greater rate of 
improvement than among men of the same age (0.17 and 0.22 years) suddenly became a 
fall in life expectancy after 2011. 
 
Table 2 Change in Life expectancy in England and Wales three-year time periods by 
age/sex (years) 
 
 
From 2004-06   2007-09       2010-12     2011-13 
 
To 2007-09   2010-12       2013-15     2014-16 
Age 65 Male 0.65 0.65             0.27           0.23 
 
Female 0.50 0.55             0.13           0.13 
Age 75 Male 0.46 0.51             0.14           0.15 
 
Female 0.38 0.44             0.07           0.09 
Age 85 Male 0.16 0.20             0.02           0.06 
 
Female 0.17 0.22            -0.04           0.01 
Source: ONS, National Life Tables, England & Wales, 2004-06 to 2014-16 
 
The final column in Table 2 shows the very latest data, made available in September 2017. It 
compares 2011-2013 with 2014-2016 and shows that there has been no end to the 
slowdown in improvements. The latest provisional weekly deaths for England and Wales 
from January to October 2017 show a crude increase of 15,605 deaths compared to the 
average of the corresponding weeks over the past 5 years.[15] This, of course, does not 
take account of age changes in the population. 
There is, therefore, no sign yet that the pattern that emerged in 2012, and which worsened 
in 2015, is temporary. Evidence from a longer period in the USA shows that there are no 
grounds for confidence that such deceleration in improvements, or even declines, will be as 
short-lived as some policy makers in the UK seem to assume.  
The fact that the changes have systematically harmed women more than men, and the very 
elderly more than the younger elderly, suggests that it is those who have less access to 
resources of all kinds that have been hardest hit. Elderly women are far more likely to live 
alone and to be poor as compared to elderly men. People aged over 85 tend to be more frail 
and, crucially, more likely to be dependent on a well-functioning health and social care 
system. As a Professor of biogerontology has recently suggested ‘…it can be argued that 
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the oldest people are highly vulnerable and that excess deaths among them – from 
underfunded services – are a major cause of the stalled life expectancy increases’.[16]  
 
Figure 3: Life expectancy age 75, England and Wales 
 
 
 
The search for causes 
Any very large change in mortality trends must be taken extremely seriously. Life 
expectancy is the most important social statistic that any country produces about itself and it 
is often an early sign of wider societal problems, as in the former USSR in the 1980s [17] or 
in the USA more recently. American life expectancy at birth stalled between 2010 and 2014 
and, in 2015, actually declined, with rising rates of causes that have been described as 
“deaths of despair”[18]concentrated among the poor in states that had experienced the 
greatest economic and social decline.[19] This has political consequences; those counties in 
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which life expectancy stagnated or declined experienced the largest increases in Republican 
votes in the 2016 Presidential election.[20]  
Some other European countries have seen slowing of improvements in life expectancy but, 
crucially, not all, and not to the extent seen in England and Wales. Whether comparison of 
the economic choices made by those countries whose life expectancy has continued to 
improve, such as Norway and Finland, to those who have seen stalling, such as France [21] 
and Germany, may help understand this remain to be seen. However, some caution is 
required given differences in recording of deaths occurring among people temporarily 
abroad, a particular issue for older people from some Northern European countries. For 
now, we are only able to hypothesise.  
Our previous search for causes of these reversals in trends in England considered the 
possibilities of data artefact, environmental events such as war, natural disaster, or 
unusually cold weather, influenza, and failings of the health and social care system.  
One argument sometimes advanced is that, in the UK, life expectancy is reaching a 
theoretical maximum, so some slowing in the rate of improvement is inevitable. Yet, other 
countries, such as Japan, show that the UK is still far from what can be achieved with 
existing knowledge. Moreover, the overall slowing conceals how life expectancy is actually 
falling in some parts of England.[22] Influenza is likely to have played some role, but even if 
it did, questions remain as to why, as with excess winter mortality, people living in the UK 
seem to have been more likely to die from it than in some other European countries. 
Importantly, others have suggested that influenza may be overstated as a cause of 
otherwise unexplained premature deaths, at least in the USA,[23] where reversals in life 
expectancy have been similarly poorly addressed.[24] 
The elderly, who have been the most affected by the rise in mortality and stalling, and in 
some cases reversing, of life expectancy, are also the group most reliant on a well-
functioning health and social care system. In the context of the relentless underfunding of 
the health and social care system since 2010, we pointed to evidence that suggested a 
possible link between these two factors, requiring urgent review.  As long ago as February 
2014 we wrote that ‘The 2012-2013 rise appeared to be more of a trend’ and suggested 
austerity as the mostly likely immediate cause.[12] Subsequent research noted how the 
narrowing gap in life expectancy between the most and least deprived local authorities, 
which coincided with the government strategy to reduce inequalities that ended in 2010, 
began to widen between 2012 and 2015.[25]  
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Figure 4: Life expectancy age 85, England and Wales 
 
 
There are alternative suggestions, including a possible infective agent other than 
influenza.[26] However, the main debate is about whether it is still too early to conclude that 
what is observed is the beginning of a trend that should cause concern. The situation is 
complicated by delays in publication of detailed data and questions of how it should be 
interpreted.[7] In July 2017, Public Health England reviewed possible causes including 
population changes and influenza, including international comparisons, concluding there 
was not enough evidence as yet to show a change in trends.[27] Yet, as noted above, the 
Institute and Faculty of Actuaries disagrees and has revised its projection of life expectancy 
downwards, reducing predicted pension liabilities by billions of pounds.[8] Furthermore the 
life expectancy data released by ONS in September 2017 and, notwithstanding the need for 
more detailed analysis when the necessary data on deaths by detailed age category 
become available, the continued high raw death counts, adds more weight to the argument 
that we have now seen enough to know that something very important has changed. 
It is essential, for many reasons, that the divergent views over what the causes might be are 
resolved. The answer has implications for fiscal, health, and social policies among many 
others. Most recently, Sir Michael Marmot has called for an urgent investigation into whether 
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spending cuts are impacting length of life, with evidence that they have already impacted on 
quality of life.[28] Other research has found a link between cuts in payments to pensioners 
and mortality,[29] and delay in NHS discharges and mortality.[30] Most recently, research 
implicated ‘spending constraints’ as contributing to 45,368 (95% CI 34,530 to 56,206) extra 
deaths from 2010 to 2014, compared to pre-2010 trends, predominantly in people aged over 
60 years and living in care homes.[31] Correlation is not proof of causality, as all 
epidemiologists know. However, in the absence of a clear explanation or simple research 
method that could confirm a causal relationship between under-funding and increased 
mortality, simply dismissing the possibility is not justifiable. Correlation is not always 
coincidence.  
All this strengthens the case for inquiring into a possible relationship between under-funding 
and mortality. The need for answers is now even more urgent than it was last year, given the 
likely impact of Brexit on government finances and the threat to recruitment of health and 
social care staff already being experienced,[32] and the recent NHS ‘crisis’. The question 
then is who should do this inquiry? Researchers can, and must, contribute to the analyses, 
but the questions raised go beyond what can be answered by demographic analyses, 
eliciting important political issues. However, researchers, whether in non-governmental 
organisations or universities, lack the power to require production of the necessary data to 
answer the key questions.  
Once, questions of this nature might have been addressed by a Royal Commission, but 
these have gone out of favour and, anyway, they would have to be convened by ministers 
who show little inclination to do so in this case.  The urgency of finding an answer suggests 
that public inquiries, such as those into the Iraq war or Bloody Sunday, are unlikely to be 
appropriate or speedy. The one body that does have the legitimacy to conduct such an 
inquiry, coupled with the necessary powers to summon witnesses and require data to be 
made available, is parliament, with the health committees of the Commons and the Lords 
providing the obvious mechanisms.  
Conclusion 
Concerns about life expectancy have been raised by academics at least twice in 2017, and 
twice the Department of Health’s responses have been disappointing, attacking the 
researchers involved. Life expectancy in England and Wales has stalled, and in some cases 
reversed, yet there is no consensus as to why. There is a growing suspicion that prolonged 
austerity is likely to matter greatly. Opinions as to the cause range from cuts in health and 
social care,[3, 4] epidemic disease,[26] and statistical artefact.[7] All of these must be 
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explored. What is indisputable is what the data now clearly show. This is not temporary. An 
independent investigation is urgently needed, requiring time, resource, and authority to be 
carried out. If ministers are not prepared to ask the appropriate questions, someone else 
must.  
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